Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Fine tuning by human CD1e of lipid-specific immune responses.

Facciotti F, Cavallari M, Angénieux C, Garcia-Alles LF, Signorino-Gelo F, Angman L, Gilleron M, Prandi J, Puzo G, Panza L, Xia C, Wang PG, Dellabona P, Casorati G, Porcelli SA, de la Salle H, Mori L, De Libero G.

Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14228-33. doi: 10.1073/pnas.1108809108. Epub 2011 Aug 15.

2.

Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells.

Gober HJ, Kistowska M, Angman L, Jenö P, Mori L, De Libero G.

J Exp Med. 2003 Jan 20;197(2):163-8.

3.
4.

Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain.

Nakajima H, Samaridis J, Angman L, Colonna M.

J Immunol. 1999 Jan 1;162(1):5-8.

5.

Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules.

Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA, Dunbar R, Ogg GS, Cerundolo V, Rolink A.

J Immunol. 1998 Apr 1;160(7):3096-100.

6.

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.

Colonna M, Navarro F, Bellón T, Llano M, García P, Samaridis J, Angman L, Cella M, López-Botet M.

J Exp Med. 1997 Dec 1;186(11):1809-18.

7.

Clonal predominance, but preservation of a polyclonal reservoir, in the normal alpha beta T-cell repertoire.

Lantelme E, Granziero L, Angman L, Giachino C.

Hum Immunol. 1997 Mar;53(1):49-56.

PMID:
9127147
8.

T-helper- and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector.

Döhring C, Angman L, Spagnoli G, Lanzavecchia A.

Int J Cancer. 1994 Jun 1;57(5):754-9.

PMID:
7515023
9.

In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4-8- subset.

Dellabona P, Casorati G, Friedli B, Angman L, Sallusto F, Tunnacliffe A, Roosneek E, Lanzavecchia A.

J Exp Med. 1993 Jun 1;177(6):1763-71.

10.

Capping revisited. II. Low sensitivity to sulfydryl reagents.

Loor F, Martin-Pélissard C, Angman L.

Cell Immunol. 1981 Jan 1;57(1):73-8. No abstract available.

PMID:
7214535
11.

Capping revisited. III. Differential inhibitory characteristics of the various cytochalasins.

Loor F, Angman L.

Exp Cell Res. 1980 Oct;129(2):289-95. No abstract available.

PMID:
7428822

Supplemental Content

Loading ...
Support Center